abrdn Life Sciences Investors (NYSE:HQL) Stock Falls 0.1% – Here’s Why

abrdn Life Sciences Investors (NYSE:HQL) dropped 0.1% during trading on Wednesday. The company traded as low as $17.32 and last traded at $17.5450. 92,927 shares changed hands during mid-day trading, a decline of 30% from the average daily volume of 133,602 shares. The stock had previously closed at $17.56.

abrdn Life Sciences Investors Stock Down 0.1%

The firm has a 50 day simple moving average of $20.11 and a two-hundred day simple moving average of $18.77.

abrdn Life Sciences Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Monday, August 24th were paid a $0.62 dividend. The ex-dividend date of this dividend was Monday, August 24th. This represents a $2.48 dividend on an annualized basis and a dividend yield of 14.1%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Independent Financial Group LLC bought a new stake in abrdn Life Sciences Investors in the first quarter valued at approximately $211,000. Citadel Advisors LLC bought a new position in shares of abrdn Life Sciences Investors during the second quarter worth $287,000. WNY Asset Management LLC acquired a new position in shares of abrdn Life Sciences Investors in the 1st quarter valued at $239,000. Wedbush Securities Inc. increased its position in shares of abrdn Life Sciences Investors by 50.6% in the 2nd quarter. Wedbush Securities Inc. now owns 15,960 shares of the company’s stock valued at $319,000 after buying an additional 5,360 shares in the last quarter. Finally, NewEdge Advisors LLC increased its position in shares of abrdn Life Sciences Investors by 17.6% in the 1st quarter. NewEdge Advisors LLC now owns 23,788 shares of the company’s stock valued at $387,000 after buying an additional 3,562 shares in the last quarter. Institutional investors own 32.21% of the company’s stock.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a diversified, closed-end investment company focused on the life sciences sector. The fund seeks long-term capital appreciation by investing in companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services and related industries.

Its portfolio may include both publicly traded and privately held businesses across various stages of development, from emerging companies developing new therapies and technologies to more established healthcare enterprises.